BACKGROUND: In recent influenza seasons, the effectiveness of inactivated influenza vaccines against circulating A(H3N2) virus has been lower than against A(H1N1)pdm09 and B viruses, even when circulating viruses remained antigenically similar to vaccine components. METHODS: During the 2016-2017 influenza season, vaccine effectiveness (VE) across age groups and vaccine types was examined among outpatients with acute respiratory illness at 5 US sites using a test-negative design that compared the odds of vaccination among reverse transcription polymerase chain reaction-confirmed influenza positives and negatives. RESULTS: Among 7083 enrollees, 1342 (19%) tested positive for influenza A(H3N2), 648 (9%) were positive for influenza B (including B/Yamagata, n = 577), and 5040 (71%) were influenza negative. Vaccine effectiveness was 40% (95% confidence interval [CI], 32% to 46%) against any influenza virus, 33% (95% CI, 23% to 41%) against influenza A(H3N2) viruses, and 53% (95% CI, 43% to 61%) against influenza B viruses. CONCLUSIONS: The 2016-2017 influenza vaccines provided moderate protection against any influenza among outpatients but were less protective against influenza A(H3N2) viruses than B viruses. Approaches to improving effectiveness against A(H3N2) viruses are needed. Published by Oxford University Press for the Infectious Diseases Society of America 2018.
BACKGROUND: In recent influenza seasons, the effectiveness of inactivated influenza vaccines against circulating A(H3N2) virus has been lower than against A(H1N1)pdm09 and B viruses, even when circulating viruses remained antigenically similar to vaccine components. METHODS: During the 2016-2017 influenza season, vaccine effectiveness (VE) across age groups and vaccine types was examined among outpatients with acute respiratory illness at 5 US sites using a test-negative design that compared the odds of vaccination among reverse transcription polymerase chain reaction-confirmed influenza positives and negatives. RESULTS: Among 7083 enrollees, 1342 (19%) tested positive for influenza A(H3N2), 648 (9%) were positive for influenza B (including B/Yamagata, n = 577), and 5040 (71%) were influenza negative. Vaccine effectiveness was 40% (95% confidence interval [CI], 32% to 46%) against any influenza virus, 33% (95% CI, 23% to 41%) against influenza A(H3N2) viruses, and 53% (95% CI, 43% to 61%) against influenza B viruses. CONCLUSIONS: The 2016-2017 influenza vaccines provided moderate protection against any influenza among outpatients but were less protective against influenza A(H3N2) viruses than B viruses. Approaches to improving effectiveness against A(H3N2) viruses are needed. Published by Oxford University Press for the Infectious Diseases Society of America 2018.
Authors: Lisa M Dunkle; Ruvim Izikson; Peter Patriarca; Karen L Goldenthal; Derek Muse; Janice Callahan; Manon M J Cox Journal: N Engl J Med Date: 2017-06-22 Impact factor: 91.245
Authors: Edward A Belongia; Danuta M Skowronski; Huong Q McLean; Catharine Chambers; Maria E Sundaram; Gaston De Serres Journal: Expert Rev Vaccines Date: 2017-06-09 Impact factor: 5.217
Authors: Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Sonja J Olsen; Ruth A Karron; Daniel B Jernigan; Joseph S Bresee Journal: MMWR Recomm Rep Date: 2016-08-26
Authors: Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia Journal: J Infect Dis Date: 2014-11-18 Impact factor: 5.226
Authors: Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; James A Dickinson; Anne-Luise Winter; Gaston De Serres; Steven J Drews; Agatha Jassem; Jonathan B Gubbay; Hugues Charest; Robert Balshaw; Nathalie Bastien; Yan Li; Mel Krajden Journal: Euro Surveill Date: 2017-02-09
Authors: Seth J Zost; Kaela Parkhouse; Megan E Gumina; Kangchon Kim; Sebastian Diaz Perez; Patrick C Wilson; John J Treanor; Andrea J Sant; Sarah Cobey; Scott E Hensley Journal: Proc Natl Acad Sci U S A Date: 2017-11-06 Impact factor: 11.205
Authors: Feng Liu; F Liaini Gross; Stacie N Jefferson; Crystal Holiday; Yaohui Bai; Li Wang; Bin Zhou; Min Z Levine Journal: J Clin Invest Date: 2021-04-15 Impact factor: 14.808
Authors: Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: Leora R Feldstein; Wesley H Self; Jill M Ferdinands; Adrienne G Randolph; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Matthew C Exline; D Clark Files; Kevin Gibbs; Adit A Ginde; Michelle N Gong; Carlos G Grijalva; Natasha Halasa; Akram Khan; Christopher J Lindsell; Margaret Newhams; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay Steingrub; H Keipp Talbot; M Elizabeth Halloran; Manish Patel Journal: Clin Infect Dis Date: 2021-05-04 Impact factor: 9.079
Authors: Brendan Flannery; Rebecca J Garten Kondor; Jessie R Chung; Manjusha Gaglani; Michael Reis; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Sara S Kim; Lenee Blanton; Krista Kniss; Alicia P Budd; Lynnette Brammer; Thomas J Stark; John R Barnes; David E Wentworth; Alicia M Fry; Manish Patel Journal: J Infect Dis Date: 2020-01-01 Impact factor: 5.226
Authors: Leora R Feldstein; Jill M Ferdinands; Wesley H Self; Adrienne G Randolph; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Matthew C Exline; D Clark Files; Kevin Gibbs; Adit A Ginde; Michelle N Gong; Carlos G Grijalva; Natasha Halasa; Akram Khan; Christopher J Lindsell; Margaret Newhams; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay Steingrub; H Keipp Talbot; M Elizabeth Halloran; Manish Patel Journal: J Infect Dis Date: 2021-12-15 Impact factor: 5.226
Authors: Emily T Martin; Caroline Cheng; Joshua G Petrie; Elif Alyanak; Manjusha Gaglani; Donald B Middleton; Shekhar Ghamande; Fernanda P Silveira; Kempapura Murthy; Richard K Zimmerman; Arnold S Monto; Christopher Trabue; H Keipp Talbot; Jill M Ferdinands Journal: J Infect Dis Date: 2021-06-15 Impact factor: 5.226
Authors: Michael L Jackson; Jill Ferdinands; Mary Patricia Nowalk; Richard K Zimmerman; Burney Kieke; Manjusha Gaglani; Kempapura Murthy; Joshua G Petrie; Emily T Martin; Jessie R Chung; Brendan Flannery; Lisa A Jackson Journal: BMC Public Health Date: 2021-03-16 Impact factor: 3.295